Abingdon Health Plc (ABDXF)

Market Cap	61.71M +87.7%
Revenue (ttm)	12.88M +40.4%
Net Income	-4.36M
EPS	-0.01
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,000
Open	0.1410
Previous Close	0.1401
Day's Range	0.1410 - 0.1410
52-Week Range	0.1214 - 0.2090
Beta	0.13
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 9, 2026

About Abingdon Health

Abingdon Health Plc develops, manufactures, and distributes diagnostic devices in the United Kingdom, Europe, the United States, Canada, and internationally. It operates through Contract Development, Contract Manufacturing, Product Sales, and Regulatory segments. The company provides a range of professional-use tests and self-tests to various industries, including healthcare, COVID-19, plant health, and nucleic acid detection. Abingdon Health Plc was incorporated in 2008 and is based in York, the United Kingdom.

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 2008
• Employees: 129
• Stock Exchange: OTCMKTS
• Ticker Symbol: ABDXF

Financial Performance

In fiscal year 2025, Abingdon Health's revenue was 8.43 million, an increase of 37.39% compared to the previous year's 6.14 million. Losses were -3.42 million, 168.7% more than in 2024.

Financial numbers in GBP

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Aug 12, 2026

Data Sources Report a data error